However, there was no correlation between ORM2 expression and other clinicopathological factors, such as age, gender, tumor size, the presence of cirrhosis, serum alpha-fetoprotein (AFP) and hepatitis B surface antigen (HBsAg) levels (Table 1). Here, ORM2 is linked to neoplasm.